1 分钟阅读
Feb 7 (Reuters) - Taro Pharmaceutical Industries Ltd :
* EXCLUDING IMPACT OF ONE-TIME TAX RE-MEASUREMENT, EARNINGS PER SHARE FOR QUARTER WOULD BE $1.37 Source text for Eikon: Further company coverage: